High-resolution structural model of porcine P2 myelin membrane protein with associated fatty acid ligand: Fact or artifact?

Journal of Neuroscience Research

Volumn 89, Issue 6, 2011, Pages 909-920

  Sedzik, Jan ^a   Jastrzebski, Jan Pawel ^b,c  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^c National Institute for Natural Sciences   (Japan)

Author keywords

CRAC motif; Fatty acid ligands; Myelin; Neurodegeneration; P2 protein; Phosphorylation

Indexed keywords

CARBON; CHOLESTEROL ESTER; ELAIDIC ACID; FATTY ACID; FATTY ACID LIGAND; GAMMA LINOLENIC ACID; LIGAND; LINOLEIC ACID; LINOLENIC ACID; MYELIN; MYELIN PROTEIN; MYELIN PROTEIN P2; OLEIC ACID; RECOMBINANT PROTEIN; STEARIC ACID; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; ARTIFACT; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; LIPID RAFT; MASS SPECTROMETRY; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PURIFICATION; PROTEIN STABILITY; PROTEIN STRUCTURE; SPINAL ROOT; STRUCTURE ACTIVITY RELATION; SWINE;

ANIMALS; CRYSTALLOGRAPHY, X-RAY; FATTY ACIDS; LIGANDS; MASS SPECTROMETRY; MODELS, CHEMICAL; MOLECULAR WEIGHT; MYELIN P0 PROTEIN; MYELIN SHEATH; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEOMICS; SPINAL NERVE ROOTS; SWINE;

EID: 79954594702     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22612     Document Type: Article

References (83)

1. Adelmann M, Linington C. 1992. Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein. Neurochem Res 17: 887-891.
2. Bjellqvist B, Hughes GJ, Pasquali C, Paquet N, Ravier F, Sanchez JC, Frutiger S, Hochstrasser D. 1993. The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences. Electrophoresis 14: 1023-1031.
3. Bonk T, Humeny A. 2001. MALDI-TOF analysis of protein and DNA. Neuroscientists 7: 6-12.
4. Boyanapalli M, Kottis V, Lahoud O, Bamri-Ezzine S, Braun PE, Mikol DD. 2005. Oligodendrocyte-myelin glycoprotein is present in lipid rafts and caveolin-1-enriched membranes. Glia 52: 219-227.
5. Breslow JL. 2006. n-3 Fatty acids and cardiovascular disease. Am J Clin Nutr 83: 1477S-1482S.
6. Caspar DLD, Kirschner DA. 1971. Myelin membrane structure at 10Å resolution. Nature 231: 46-49.
7. Cavaletti G, Matà S, Fasano A, Lolli F, Riccio P, Celon S, Marmiroli P, Tredici G. 2000. Lipid-free vs. lipid-bound P2 protein-induced experimental allergic neuritis: clinicopathological, neurophysiological, and immunological study. J Neurosci Res 62: 709-716.
8. Chmurzynska A. 2006. The multigene family of fatty acid-binding protein FABPs function, structure and polymorphism. J Appl Genet 47: 39-48.
9. Connor WE. 2000. Importance of n-3 fatty acids in health and disease. Am J Clin Nutr 71: 171S-175S.
10. Coulombe R, Yue KQ, Ghisla S, Vrielink A. 2001. Oxygen access to the active site of cholesterol oxidase through a narrow channel is gated by an Arg-Glu pair. J Biol Chem 276: 30435-30441.
11. Cournia Z, Ullmann GM, Smith JC. 2006. Differential effects of cholesterol, ergosterol and lanosterol on a dipalmitoyl phosphatidylcholine membrane: a molecular dynamics simulation study. J Phys Chem 111: 1786-1801.
12. 14C]linoleate oxidation. J Lipid Res 38: 805-812.
13. Das UN. 2006. Essential fatty acids-a review. Curr Pharm Biotechnol 7: 467-482.
14. DeBruin LS, Harauz G. 2007. White matter rafting-membrane micro-domains in myelin. Neurochem Res 32: 213-228.
15. DeBruin LS, Haines JD, Bienzle D, Harauz G. 2006. Partitioning of myelin basic protein into membrane microdomains in a spontaneously demyelinating mouse model for multiple sclerosis. Biochem Cell Biol 84: 993-1005.
16. DiBiase A, Salvati S, Crescenzi GS. 1989. Analysis of brain and myelin lipids by high-performance thin layer chromatography and densitometry. Neurochem Res 14: 153-156.
17. Dundas J, Ouyang Z, Tseng J, Binkowski A, Turpaz Y, Liang J. 2006. CASTp: computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Res 34(web server issue): W116-W118.
18. Epand RM. 2008. Proteins and cholesterol-rich domains. Biochim Biophys Acta 1778: 1576-1582.
19. Fasano A, Amoresano A, Rossano R, Carlone G, Carpentieri A, Liuzzi GM, Pucci P, Riccio P. 2008. The different forms of PNS myelin P0 protein within and outside lipid rafts. J Neurochem 1007: 291-301.
20. Gimeno R. 2007. Fatty acid transport proteins. Curr Opin Lipidol 18: 271-276.
21. Goodrum JF, Weaver JE, Goines ND, Bouldin TW. 1995. Fatty acids from degenerating myelin lipids are conserved and reutilized for myelin synthesis during regeneration in peripheral nerve. J Neurochem 65: 1752-1759.
22. Graff JM, Stumpo DJ, Blackshear PJ. 1989. Characterization of the phosphorylation sites in the chicken and bovine myristoylated alanine-rich C kinase substrate protein, a prominent cellular substrate for protein kinase C. J Biol Chem 264: 11912-11919.
23. Greenfield S, Brostoff S, Eylar EH, Morell P. 1973. Protein composition of myelin of the peripheral nervous system. J Neurochem 20: 1207-1216.
24. Hahn AF. 1996. Experimental allergic neuritis EAN as a model for the immune-mediated demyelinating neuropathies. Rev Neurol (Paris) 152: 328-332.
25. Heijne von G, Sedzik J. 2009. Bioinformatics of myelin membrane proteins. In: Sedzik J, Riccio P, editors. Molecules, aggregation, nucleation and crystallization-beyond medical and other implications. Hackensack, NJ: World Scientific Publishing Co. p 35-53.
26. Hresko RC, Bernier M, Hoffman RD, Flores-Riveros RD, Liao K, Laird DM, Lane MD. 1988. Identification of phosphorylated 422aP2. protein as pp15, the 15-kilodalton target of the insulin receptor tyrosine kinase in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 85: 8835-8839.
27. Hughes RA, Hadden RD, Gregson NA, Smith KJ. 1999. Pathogenesis of Guillain-Barré syndrome. J Neuroimmunol 100: 74-97.
28. Hunter DJ, Macmaster R, Roszak AW, Riboldi-Tunnicliffe A, Griffiths IR, Freer AA. 2005. Structure of myelin P2 protein from equine spinal cord. Acta Crystallogr D Biol Crystallogr 61: 1067-1071.
29. Hunter JE, Zhang J, Kris-Etherton PM. 2010. Cardiovascular disease risk of dietary stearic acid compared with trans, other saturated, and unsaturated fatty acids: a systematic review. Am J Clin Nutr 91: 46-63.
30. Jahn O, Tenzer S, Werner HB. 2009. Myelin proteomics: molecular anatomy of an insulating sheath. Mol Neurobiol 40: 55-72.
31. Jones TA, Bergfors T, Sedzik J, Unge T. 1988. The three-dimensional structure of P2 myelin protein. EMBO J 7: 1597-1604.
32. Jørgensen FGH, Hobolth A, Hornshoj H, Bendixen C, Fredholm M, Schierup MH. 2005. Comparative analysis of protein coding sequences from human, mouse and the domesticated pig. BMC Biol 3: 2.
33. Kadlubowski M, Hughes RA. 1980. The neuritogenicity and encephalitogenicity of P2 in the rat, guinea-pig and rabbit. Neurol Sci 8: 1-178.
34. Kadlubowski M, Hughes RAC, Gregson NA. 1984. Spontaneous and experimental neuritis and the distribution of the myelin protein P2 in the nervous system. J Neurochem 42: 123-129.
35. Karthigasan J, Kosaras B, Nguyen J, Kirschner DA. 1994. Protein and lipid composition of radial component-enriched CNS myelin. J Neurochem 62: 1203-1213.
36. Kirschner DA, Blaurock AE. 1992. Organization, phylogenetic variation and dynamic transition of myelin. In: Martenson RE, editor. Myelin: biology and chemistry. Boca Raton, FL: CRC Press. p 3-73.
37. Kitamura K, Suzuki M, Suzuki A, Uyemura K. 1980. The complete amino acid sequence of the P2 protein in bovine peripheral nerve myelin. FEBS Lett 115: 27-30.
38. Kyte J, Doolittle RF. 1982. A simple method for displaying the hydrophobic character of a protein. J Mol Biol 157: 105-142.
39. Lee AG. 2001. Myelin: delivery by raft. Curr Biol 11: R60-R62.
40. Li H, Papadopoulos V. 1998. Peripheral type benzodiazepine receptor function in cholesterol transport. Identification of putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139: 4991-4997.
41. Linington C, Lassmann H, Ozawa K, Kosin S, Mongan L. 1992. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis EAN by P0 protein-specific T cell lines. Eur J Immunol 22: 1813-1817.
42. Lomize MA, Lomize AL, Pogozheva ID, Mosberg HI. 2006. OPM: orientations of proteins in membranes database. Bioinformatics 22: 623-625.
43. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
44. Maddalo G, Shariatgorji M, Adams CM, Fung E, Nilsson U, Zubarev RA, Sedzik J, Ilag LL. 2010. Porcine P2 myelin protein primary structure and bound fatty acids determined by mass spectrometry. Anal Bioanal Chem 397: 1903-1910.
45. Majava V, Polverini E, Mazzini A, Nanekar R, Knoll W, Peters J, Natali F, Baumgärtel P, Kursula I, Kursula P. 2010. Structural and functional characterization of human peripheral nervous system myelin protein P2. PLoS One 5: e10300.
46. Mastronardi FG, Moscarello MA. 2005. Molecules affecting myelin stability:a novel hypothesis regarding the pathogenesis of multiple sclerosis. J Neurosci Res 80: 301-308.
47. Meeteren ME, van Baron W, Beerman C, Dijkstra CD, van Tol EAF. 2006. Polyunsaturated fatty acid supplementation stimulates differentiation of oligodendroglia cells. Dev Neurosci 28: 196-208.
48. Natali F, Relini A, Gliozzi A, Rolandi R, Cavatorta P, Deriu A, Fasano A, Riccio P. 2004. The influence of the lipid-protein interaction on the membrane dynamics. Phys B Phys Condensed Matter 350: 1-3.
49. Norton WT, Poduslo SE. 1973. Myelination in rat brain:method of myelin isolation. J Neurochem 21: 749-757.
50. Philbrick DJ, Mahadevappa VG, Ackman RG, Holub BJ. 1987. Ingestion of fish oil or a derived n-3 fatty acid concentrate containing eicosapentaenoic acid EPA, affects fatty acid compositions of individual phospholipids of rat brain, sciatic nerve and retina. J Nutr 117: 1663-1670.
51. Pritchard J. 2000. Novel therapeutic approaches to Guillain-Barré syndrome. Expert Opin Invest Drugs 9: 2307-2318.
52. Riccio P, Zito F, Fasano A, Liuzzi GM, Lolli F, Polverini F, Cavatorta P. 1998. Purification of bovine P2 myelin protein with bounds lipids. Neuroreport 9: 2769-2773.
53. 2 protein is a T cell epitope for the induction of experimental autoimmune neuritis. Cell Immunol 132: 433-441.
54. Saher G, Brügger B, Lappe-Siefke C, Möbius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, Nave KA. 2005. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8: 468-475.
55. Saher G, Quintes S, Möbius W, Wehr MC, Krämer-Albers EM, Brügger B, Nave KA. 2009. Cholesterol regulates the endoplasmic reticulum exit of the major membrane protein P0 required for peripheral myelin compaction. J Neurosci 29: 6094-6104.
56. Sedzik J. 2008. Myelin sheaths and autoimmune response induced by myelin proteins and alphaviruses. I. Physicochemical background. Curr Med Chem 15: 1899-1910.
57. Sedzik J, Hjertén S. 1994. Has the myelin basic protein esterase activity? Abstracts of the 16th International Congress of Biochemistry and Molecular Biology, New Delhi, India, September 19-22, vol II, p 378.
58. Sedzik J, Blaurock AE, Hoechli M. 1985. Reconstituted P2/myelin-lipid multilayers. J Neurochem 45: 844-852.
59. Sedzik J, Bergfors T, Jones TA, Weise M. 1988. Bovine P2 myelin basic protein crystallizes in three different forms. J Neurochem 50: 1908-1913.
60. Sedzik J, Mohammad J, Hjertén S. 1995. Myelin basic protein purified on an on-exchange continuous polymer bed in the presence of ethylene glycol and salt possesses activity against p-nitrophenyl acetate. Neurochem Res 20: 651-658.
61. 2+-immobilized metal affinity chromatography. Neurochem Res 24: 723-732.
62. Sedzik J, Uyemura K, Tsukihara T. 2002. Towards crystallization of hydrophobic myelin glycoprotein: P0 and PASII/PMP22. Prot Express Purif 26: 368-377.
63. Sedzik J, Carlone G, Fasano A, Liuzzi GM, Riccio P. 2003. Crystals of P2 myelin protein in lipid-bound form. J Struct Biol 142: 292-300.
64. Sedzik J, Matsuura T, Kotake Y, Hedman E, Tsukihara T. 2005. Structural proteomics and crystallomic of porcine P2 myelin protein. J Neurochem 94(Suppl 2): 201-202.
65. Sedzik J, Wu B, Maddalo G, Ilag L, Tang L, Wang W, Jiang T. 2006. Crystallomics at Work-P2 myelin protein and bound fatty acid. First International Conference of Nanobiomedical Technology and Structural Biology, Chengdu, Sichuan, China, June 25-29, p 86.
66. Sedzik J, Tang L, Wang WH, Wu B, Jiang T. 2008. Fatty acid ligand in P2 protein-fact or fiction? The Third ISN Special Neurochemistry Conference and 8th International Meeting for Brain Energy Metabolism-Neurodegeneration and Regeneration, Beijingm China, June 27-July 1, p 58.
67. Sedzik J, Matsuura T, Jastrzebski JP, Tao J. 2009. Imaging of myelin membrane raft. J Neurochem 110(Suppl 2): 126-127.
68. Simons K, Ikonen E. 1997. Functional rafts in cell membranes. Nature 387: 569-572.
69. Takada R, Saitoh M, Mori T. 1993. Dietary γ-linolenic acid-enriched oil reduces body fat content and induces liver enzyme activities relating to fatty acid β-oxidation in rats. J Nutr 124: 469-475.
70. Tarrant MK, Cole PA. 2009. The chemical biology of protein phosphorylation. Annu Rev Biochem 78: 797-825.
71. Thumser EA, Storch J. 2000. Liver and intestinal fatty acid-binding proteins obtain fatty acids from phospholipid. J Lipid Res 41: 647-656.
72. Trapp BD, McIntyre LJ, Quarles RH, Sternberger NH, Webster HD. 1979. Immunocytochemical localization of rat peripheral nervous system myelin proteins: P2 protein is not a component of all peripheral nervous system myelin sheaths. Proc Natl Acad Sci U S A 76: 3552-3556.
73. Uyemura K, Yoshimura K, Suzuki M, Kitamura K. 1984. Lipid binding activities of the P2 protein in peripheral nerve myelin. Neurochem Res 9: 1509-1514.
74. Veerkamp JH, Zimmerman AW. 2000. Fatty acid binding proteins of nervous tissue. J Mol Neurosci 12: 133-143.
75. Weise MJ, Brostoff SW. 1985. Research methods in studies with P2 basic protein. Res Methods Neurochem 6: 263-302.
76. WHO Technical Report Series 916, Report of a Joint WHO/FAO Expert Consultation, 2003. Diet, nutrition and the prevention of chronic diseases, Geneva, Switzerland. p 88.
77. Yamamoto N, Saitoh M, Moriuchi A, Nomura M, Okuyama H. 1988. Effect of the dietary alpha linolenate/linoleate balance on lipid compositions and learning ability of rats. II. Discrimination process, extinction process and glycolipid compositions. J Lipid Res 29: 1013-1021.
78. Yamamoto N, Hashimoto A, Takemoto Y, Okuyama H, Nomura M, Kitajima R, Togashi T, Tamai Y. 2007. Dietary lipids impacts on healthy ageing. Lipids 42: 821-825.
79. Yin X, Kidd GJ, Nave KA, Trapp BD. 2008. P0 protein is required for and can induce formation of Schmidt-Lantermann incisures in myelin internodes. J Neurosci 28: 7068-7073.
80. Zalc B, Goujet D, Colman D. 2008. The origin of the myelination program in vertebrates. Curr Biol 18: R511-R512.
81. Zand R, Agrawal K. 1981. Inhibition of myelin basic protein esterase activity-a structure probe. Trans Am Soc Neurochem 12: 255.
82. Zand R, Agrawal, K. 1982. Does myelin basic protein contain an esterolytic site? Trans Am Soc Neurochem 13: 255.
83. Zand R, Smith M. 1979. The esterase activity of bovine myelin basic protein at pH 8.0. Trans Am Soc Neurochem 10: 218.